Recently diagnosed with HIV? Click here

Treating HIV

Recent advances in HIV treatments mean that people living with HIV are leading longer and more productive lives.

NAPWHA works with pharmaceutical companies, educators, clinicians and government to ensure we have access to the best treatments and information possible. NAPWHA Health & Treatments projects are also actively representing the interests of positive people in many ways.

Treataware (formerly the AIDS Treatment Project Australia) develops educational materials and organises the popular Treatments Information Roadshow and Chin Wag events all around Australia.

For detailed information about specific anti-HIV treatments, visit NAPWHA's HIV Treatments Database.

For detailed information about when to start treatment, go to When to start treatment

Hepatitis C - an improving treatment outlook

Positive Living article • Paul Kidd • 28 February 2014

Good news for people living with HIV and hepatitis C co-infection. New treatments are on the way, says Paul Kidd. read more »

Tackling pain

Positive Living article • Luke Richards • 28 February 2014

Learn more about how to manage pain, including peripheral neuropathy-related pain, from osteopath Luke Rickards. read more »

The HIV top 10

Positive Living article • David Menadue • 28 February 2014

What are the hot issues in HIV this year? What gains have we made and what challenges are still before us? David Menadue and Adrian Ogier come up with their top 10. read more »

Increase in all PBS prescription co-payments from January 1st 2014

Media release • 10 January 2014

On 1st January the annual increase to the cost of co-payments for prescriptions for 2014 came into effect. read more »

The reverse transcriptase inhibitor

Positive Living article • Jae Condon • 2 December 2013

After HIV fuses with the membrane of a CD4 cell it releases its capsid into the CD4 cell. An HIV capsid is a coneshaped protein shell that contains the genetic material that HIV needs to replicate: two single strands of RNA and three enzymes—reverse transcriptase, integrase and protease. Most antiretroviralA medication or other substance which is active against retroviruses such as HIV. treatments (ART) are named after and classed according to which of these enzymes they inhibit. read more »

The truth about Truvada

Positive Living article • Neil McKellar-Stewart • 1 December 2013

Now that it’s being offered as PrEP, Neil McKellar-Stewart thought it was time we looked a bit closer at the big blue pill. read more »

People with HIV asked to choose treatment

Story • Adrian Ogier • 30 November 2013
Treating HIV

World AIDS Day on Sunday 1 December is time to focus on the health of people living with HIV in New South Wales.

Recent statistics show that as many as 50% of people diagnosed with HIV in Australia are not taking treatment; and Positive Life NSW, the organisation representing people living with HIV in this state, is asking people to think seriously about their choices. read more »


Resource • 24 October 2013

iPlan is a resource designed to help people living with HIV to become active partners in their health care. It also aims to help people understand and monitor some of the more important health concerns people with HIV may need or choose to explore.

iPlan was developed by NAPWHA through an unrestricted educational grant from ViiV Healthcare. read more »

Poz Action 2 - Antiretroviral co-payments for people with HIV in Australia

Promoting HIV treatment uptake, making access to treatment easier and supporting treatment adherence are key factors in achieving improved health outcomes for people with HIV in Australia. Antiretroviral treatment [ART] inhibits immune destruction and inflammation associated with the development of cardiovascular disease, renal, hepatic, and neurological disease, malignancies and other serious non-AIDS diseases. It also reduces the onward transmission of HIV. Most scientists agree that ARVA medication or other substance which is active against retroviruses such as HIV. treatment will likely have a similar impact in reducing HIV transmission among other populations. read more »

The entry inhibitor

Positive Living article • Jae Condon • 30 August 2013

HIV is unable to replicate by itself, so needs a host cell to be able to reproduce and make more HIV. That host cell is the human CD4 cell, also called a T-cell. To begin this replication cycle HIV must first enter the CD4 cell, and this entry process involves a number of stages. read more »

Syndicate content
Text size: font smallerfont normalfont larger

External links

Stay in touch

NAPWHA's email newsletters provide regular info about issues affecting people with HIV and the response to HIV in Australia. Click here to subscribe.

Subscribe to Positive Living

Our free quarterly newsmagazine, Positive Living provides authoritative, independent information about living with HIV and HIV treatments. Click here to subscribe.

RSS feeds

Our website has RSS feeds covering all topic areas — just go to the topic area you're interested in and click the RSS feed icon.

Twitter users can stay up-to-date with NAPWHA's work and be alerted to new content on the website by following @napwa.

Join us on Facebook NAPWHA Facebook.

Find out more at LinkedIn

Find out more about NAPWHA at LinkedInNAPWHA at LinkedIn.